Regulation of HLA-DR, DP, and DQ expression in activated T cells. 1988

B Gansbacher, and K S Zier
Memorial-Sloan Kettering Cancer Center, Hematology/Lymphoma Section, New York, NY 10021.

Class II expression following restimulation of a population of T cells which had first been activated and then allowed to revert to small resting cells via IL-2 deprivation was followed on the cell surface and mRNA levels. Our interest was to determine the kinetics of class II expression during in vitro growth, the triggers which can induce them, and also whether similar or different patterns are observed for the three class II antigens, DR, DQ, and DP. The cells responded rapidly to restimulation with conditioned medium containing IL-2 as assessed by increased incorporation of [3H]TdR into DNA. Cell surface expression of HLA-DR reached peak levels by Day 1, and greater than 90% of the cells continued to express DR until Day 4, when the number of positive cells gradually began to decline. The expression of DP also increased, though maximum levels were not reached until Day 3, when it began to decline. The percentage of cells positive for DP was, however, consistently lower than that of DR. DQ was expressed by very few cells, but appeared to increase until Day 4 and then decline. Tac expression was dramatically up-regulated following IL-2 stimulation, remaining high until Day 4, and then declining more precipitously than any of the other antigens. Class I antigen expression was relatively constant during the entire culture period, though a slight decline was noted between Day 5 and 6 when proliferation and viability were at their lowest levels. On the molecular level, DR beta mRNA accumulation peaked at Day 3, then rapidly declined. Reculture in IL-2 on Day 4 resulted in transient reaccumulation of message. Study of DP beta and DQ beta mRNA demonstrated strong expression on Days 3 and 4 and no obvious up-regulation after restimulation with IL-2 on Day 4. The kinetics of Tac mRNA accumulation and the response to restimulation with IL-2 closely resembled that of DR. Finally we compared the ability of different signals to up-regulate class II mRNA and surface expression and to restimulate proliferation. Our results indicated that PHA was more effective then medium alone, but far less effective than was IL-2. PMA was essentially no different than medium alone.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006682 HLA-DP Antigens A group of the D-related HLA antigens (human) found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-PL Antigens,HLA-SB Antigens,HLA-DP,HLA-PL,HLA-SB,Antigens, HLA-DP,Antigens, HLA-PL,Antigens, HLA-SB,HLA DP Antigens,HLA PL Antigens,HLA SB Antigens
D006683 HLA-DQ Antigens A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-DC Antigens,HLA-MB Antigens,HLA-DC,HLA-DQ,HLA-DS,HLA-DS Antigens,HLA-LB,HLA-LB Antigens,HLA-MB,Antigens, HLA-DC,Antigens, HLA-DQ,Antigens, HLA-DS,Antigens, HLA-LB,Antigens, HLA-MB,HLA DC Antigens,HLA DQ Antigens,HLA DS Antigens,HLA LB Antigens,HLA MB Antigens
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Gansbacher, and K S Zier
June 1986, Journal of immunology (Baltimore, Md. : 1950),
B Gansbacher, and K S Zier
October 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
B Gansbacher, and K S Zier
January 1991, Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
B Gansbacher, and K S Zier
June 1993, Bollettino della Societa italiana di biologia sperimentale,
B Gansbacher, and K S Zier
January 1989, Kidney international,
B Gansbacher, and K S Zier
April 1986, Transplantation proceedings,
B Gansbacher, and K S Zier
January 1991, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
B Gansbacher, and K S Zier
March 1987, Journal of immunology (Baltimore, Md. : 1950),
B Gansbacher, and K S Zier
February 2001, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!